Akibah Health is simplifying diabetes management with the world's first smartphone case glucose meter, GluCase.
Diabetes is a pandemic. There are 422M people worldwide and 30M in the U.S. who have diabetes. UnitedHealth Group predicts that over half of all American adults will become diabetic or pre-diabetic by 2020. People with diabetes are forced to monitor and manage their condition with devices that are inconvenient, bulky, and unintuitive. Moreover, the data around their condition is not utilized for insights to improve their health.
AkibaH's flagship product, GluCase, empowers people with diabetes to live their lives untethered from bulky meters, cables, and testing supplies. GluCase is an all-in-one solution embedded into a smartphone case, seamlessly integrating a glucose monitoring system and a Bluetooth module. Users can view glucose readings in the context of other actionable information (activity, diet, and medications) and receive real-time coaching from their care team via a mobile app, enabling the delivery of better preventative care.
First-run production is expected to ship in the next few monthsSeptember, 2017
FDA-approved meter and test strips via partnership with AgaMatrixJune, 2017
Negotiating first B2B partnership with insurance plan (estimated $10M+ annual recurring revenue)June, 2017
$50,000 in pre-order sales in fewer than 30 daysJanuary, 2016
Commercialization partnership with OtterBox: #1 smartphone case in North AmericaJuly, 2016
Backed by Techstars, Sprint, Jumpstart Foundry, & Seamless IoTJune, 2017